LOGIN  |  REGISTER
Astria Therapeutics

Cardinal Health (NYSE: CAH) Stock Quote

Last Trade: US$111.90 -0.64 -0.57
Volume: 1,548,062
5-Day Change: 0.01%
YTD Change: 11.01%
Market Cap: US$27.220B

Latest News From Cardinal Health

DUBLIN, Ohio , March 26, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access... Read More
DUBLIN, Ohio , March 15, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions reduction targets. Targets are considered science-based if they align with what the latest climate science says is necessary to limit global warming to 1.5°C above pre-industrial levels.... Read More
Study reveals impact of dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability DUBLIN, Ohio , Feb. 29, 2024 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2024 Biosimilars Report: insights on a pivotal year of evolution and expansion, an analysis of key recent economic, competitive, legislative and societal developments in... Read More
DUBLIN, Ohio , Feb. 28, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors has elected Robert "Bob" Azelby as an independent director, effective March 1. Mr. Azelby joins the board with over 30 years of experience, including as a Chief Executive Officer and board member for large, matrixed organizations in the biopharmaceutical, oncology and other specialty industries. Mr. Azelby has... Read More
DUBLIN, Ohio , Feb. 6, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on April 15, 2024 to shareholders of record at the close of business on April 1, 2024 . About Cardinal Health Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and... Read More
DUBLIN, Ohio , Feb. 6, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today released its Fiscal 2023 Environmental, Social and Governance (ESG) Report , highlighting the company's work toward building a healthier, more equitable future. "At Cardinal Health, we approach ESG in a way that supports our business, positions us as a partner of choice for customers and suppliers, and ensures compliance with evolving regulatory... Read More
Revenue increased 12% to $57.4 billion GAAP 1 operating earnings were $482 million ; GAAP diluted EPS was $1.43 Non-GAAP operating earnings increased 20% to $562 million ; non-GAAP diluted EPS increased 38% to $1.82 Fiscal 2024 non-GAAP EPS guidance raised to $7.20 to $7.35 , from $6.75 to $7.00 2,3 Fiscal 2024 non-GAAP adjusted free cash flow guidance raised to ~$2.5 billion , from ~$2.0 billion Cardinal Health to acquire... Read More
Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates platform for Cardinal Health expansion across specialty therapeutic areas Transaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ Network DUBLIN, Ohio , Jan. 31, 2024 /PRNewswire/ --... Read More
Progress achieved on company's ongoing business and portfolio review Completed review of growth businesses within the Medical Segment: investing in and further developing at-Home Solutions and OptiFreight ® Logistics as part of the company's portfolio for long-term growth and value creation Review of Global Medical Products and Distribution business continues, with focus on driving operational performance through the Medical... Read More
DUBLIN, Ohio , Jan. 2 , 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2024 on February 1 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No... Read More
DUBLIN, Ohio , Nov. 14, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on January 15, 2024 to shareholders of record at the close of business on January 2, 2024 . About Cardinal Health Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and... Read More
SmartGown™ EDGE is the first pocketed surgical gown designed to help maintain instrument sterility and accessibility. DUBLIN, Ohio , Nov. 9, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its SmartGown™ EDGE Breathable Surgical Gown with ASSIST™ Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room. Exclusively available from... Read More
Revenue increased 10% to $54.8 billion GAAP 1 operating loss was $14 million and GAAP diluted EPS was $0.02 , driven by a Medical segment goodwill impairment Non-GAAP operating earnings increased 35% to $571 million , driven by significant increases in both Pharmaceutical segment profit and Medical segment profit; non-GAAP diluted EPS increased 44% to $1.73 Pharmaceutical segment profit grew 18% to $507 million and the... Read More
DUBLIN, Ohio , Oct. 18, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) has been named among the 100 Best Corporate Citizens, a prestigious annual ranking by 3BL Media that assesses the environmental, social and governance (ESG) transparency and performance of the 1,000 largest public companies in the U.S. "We're honored to be included among the 100 Best Corporate Citizens," said Cardinal Health CEO Jason Hollar. "Our ESG... Read More
The next generation in enteral feeding, Kangaroo OMNI™ delivers nutrition and hydration from hospital to home. DUBLIN, Ohio , Sept. 28, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its Kangaroo OMNI™ Enteral Feeding Pump, designed to help provide enteral feeding patients with more options to meet their personalized needs throughout their enteral feeding journey. Kangaroo OMNI™ is the... Read More
DUBLIN, Ohio , Sept. 26, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2024 on November 3 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No... Read More
Cardinal Health Foundation will invest $1.7M to help 14 children's hospitals nationwide prevent youth suicide. DUBLIN, Ohio , Sept. 13, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) in partnership with Children's Hospitals Association (CHA) and the Zero Suicide Institute (ZSI) announced today the second round of grant recipients for the Preventing Youth Suicide: A Cardinal Health Foundation National Collaborative. The... Read More
The NTrainer™ System 2.0 is the only FDA Class II biofeedback device designed to help newborns and infants born prematurely develop their non-nutritive sucking skills needed for independent oral feeding. DUBLIN, Ohio , Aug. 30, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the launch of its next generation NTrainer™ System 2.0, a medical device designed to help premature and newborn infants develop the... Read More
Fourth quarter revenue increased 13% to $53.5 billion Fourth quarter GAAP 1 operating earnings were $137 million and GAAP diluted loss per share was $0.25 Fourth quarter non-GAAP operating earnings increased 24% to $560 million and non-GAAP diluted EPS increased 48% to $1.55 Fourth quarter Pharmaceutical segment profit increased 12% to $504 million and Medical segment profit increased to $82 million Generated both operating... Read More
DUBLIN, Ohio , Aug. 9, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on October 15, 2023 to shareholders of record at the close of business on October 3, 2023 . About Cardinal Health Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and... Read More
DUBLIN, Ohio , July 5, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2023 on August 15 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations... Read More
New facility is the largest at-Home Solutions has built to date, set to accommodate continued business and home healthcare industry growth DUBLIN, Ohio , June 15, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today its plans to build a new distribution center in the Greenville, South Carolina , area, to support its at-Home Solutions business, a market-leading home healthcare medical supplies provider serving... Read More
Narrowing fiscal year 2023 non-GAAP diluted EPS guidance to $5.65 to $5.80 , from $5.60 to $5.80 (13% growth at the mid-point) 1 Providing preliminary fiscal year 2024 non-GAAP diluted EPS guidance of $6.45 to $6.70 (15% growth at the mid-points) Providing long-term financial targets reflecting 12% to 14% growth of non-GAAP diluted EPS (3-year CAGR) 2 Raising long-term financial target for Pharmaceutical segment profit to 4%... Read More
Cardinal Health's Outcomes™ business will combine with Transaction Data Systems to offer improved patient engagement and clinical pharmacy solutions, expanding connections between payers and pharma to its nationwide pharmacy network DUBLIN, Ohio , June 5, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced it has signed a definitive agreement to contribute its Outcomes™ business to Transaction Data Systems... Read More
DUBLIN, Ohio and SAN FRANCISCO , May 31, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launched modern payment solutions, powered by Square , to help independent pharmacies increase operational efficiency, stay current with customer payment preferences, and access integrated software tools for their business. The collaboration with Square allows Cardinal Health to offer its independent pharmacy customers access to... Read More
DUBLIN, Ohio , May 11, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to the Company's quarterly dividend, to $0.5006 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2023 to shareholders of record at the close of business on July 3, 2023 . About Cardinal Health Cardinal Health is a distributor of pharmaceuticals, a... Read More
New facility to utilize state-of-the-art robotics technology to drive efficiencies and accuracy TORONTO , May 10, 2023 /CNW/ -- Cardinal Health Canada (NYSE: CAH) announced today plans to open a new distribution center in the Greater Toronto Area (GTA), expanding its distribution footprint to nine strategic locations to better meet the medical and surgical product demands of the Canadian healthcare system. The 163,000... Read More
Revenue increased 13% to $50.5 billion GAAP 1 operating earnings were $572 million ; GAAP diluted EPS was $1.34 Non-GAAP operating earnings increased 11% to $606 million ; non-GAAP diluted EPS increased 20% to $1.74 Fiscal year 2023 non-GAAP EPS guidance raised and narrowed to $5.60 to $5.80 , from $5.20 to $5.50 Fiscal year 2023 adjusted free cash flow guidance raised and narrowed to $2.0 to $2.3 billion , from $1.5 to $2.0... Read More
DUBLIN, Ohio , April 19, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the launch of the first-of-its-kind Stray Away™ hair management drape for more efficient surgical procedure preparation. The Stray Away™ drape is specifically designed and manufactured by Cardinal Health to help minimize hair from obstructing the surgical area and to improve patient preparation time and experience. Pre-operative... Read More
The new facilities represent Cardinal Health's ongoing commitment to servicing customers, warehousing modernization and growing the local economy DUBLIN, Ohio , April 17, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it is celebrating the opening of two new distribution centers in Central Ohio this month. Both facilities will support the company's Medical Segment, focusing on its U.S. Medical Products... Read More
DUBLIN, Ohio , March 30, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2023 on May 4 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access... Read More
HealthStocksHub
NEWPORT NEWS, Va. , March 16, 2023 /PRNewswire/ -- Swisslog, a leading provider of best-in-class warehouse automation and software, has announced that Cardinal Health (NYSE: CAH) will install a Swisslog Automation Solution within its new at-Home Solutions distribution center in Grove City, Ohio . The facility is part of the... Read More
DUBLIN, Ohio , March 6, 2023 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced its collaboration with Signify Health (NYSE:SGFY) to offer in-home clinical and medication management services through its Outcomes™ business. This collaboration will help reduce costs and eliminate gaps in care for more than 2.3 million members nationwide to support their treatment journey from prescription to pharmacy to home. Studies... Read More
ST. PETERSBURG, Fla., Feb. 16, 2023 (GLOBE NEWSWIRE) -- RxLive , today announced a collaboration with Outcomes , a Cardinal Health (NYSE: CAH) company, to improve data sharing and reduce communication gaps between hospitals, physicians and pharmacies. Hospital readmissions cost the U.S. healthcare system billions of dollars each year, and recent studies show that approximately a quarter of potentially avoidable readmissions... Read More
DUBLIN, Ohio , Jan. 3, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2023 on February 2 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No... Read More
HealthStocksHub
DUBLIN, Ohio , Dec. 19, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) and its board of directors announced today that Aaron Alt will become the company's new chief financial officer (CFO). Alt will succeed interim CFO, Trish English and will report to CEO, Jason Hollar , as a member of the company's Executive Committee... Read More
DUBLIN, Ohio , Dec. 9, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) released today its latest edition of Oncology Insights , a biannual, research-based report from Cardinal Health . Featuring perspectives from nearly 200 oncologists nationwide, the 12th edition of Oncology Insights focuses on patient diversity, health equity in oncology, care management and symptom monitoring. The research revealed that 80% of... Read More
Chimerix

COPYRIGHT ©2023 HEALTH STOCKS HUB